Literature DB >> 10986117

Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter.

G Caretti1, F Cocchiarella, C Sidoli, J Villard, M Peretti, W Reith, R Mantovani.   

Abstract

Transcription of major histocompatibility complex (MHC) class II genes depends upon the trimeric complexes RFX and NF-Y binding to the conserved X-Y promoter elements. We produced and purified the RFX subunits from Escherichia coli, reconstituted DNA-binding to the mouse Ea X box and dissected the interactions with NF-Y. RFX and NF-Y do not interact in solution, but make cooperative interactions in EMSA: a minimal NF-Y, composed of the evolutionary conserved domains, is sufficient and the RFXAP N-terminal half is expendable. Altering the X-Y distance abolishes cooperativity, indicating that DNA imposes severe spatial constraints. When tested on a highly positioned nucleosome, RFX binds DNA well and NF-Y does not increase its affinity further. Transfections of NF-Y subunits, but not RFX, in class II negative cells improves basal transcription and coexpression of the two activators has a synergistic effect, while modestly increasing CIITA-mediated activation. These results show that interactions between the two trimers on DNA are key to MHC class II expression. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986117     DOI: 10.1006/jmbi.2000.4028

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  CIITA regulates transcription onset viaSer5-phosphorylation of RNA Pol II.

Authors:  Charalambos Spilianakis; Androniki Kretsovali; Theodora Agalioti; Takis Makatounakis; Dimitris Thanos; Joseph Papamatheakis
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 3.  Impaired regulation of HLA-DR expression in human immunodeficiency virus-infected monocytes.

Authors:  Ling Shao; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  DNA compaction by the nuclear factor-Y.

Authors:  Rosalinda F Guerra; Laura Imperadori; Roberto Mantovani; David D Dunlap; Laura Finzi
Journal:  Biophys J       Date:  2007-04-13       Impact factor: 4.033

5.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome.

Authors:  N Nekrep; M Geyer; N Jabrane-Ferrat; B M Peterlin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.

Authors:  Kholiswa M Laird; LaTese L Briggs; Jeremy M Boss; Michael F Summers; Colin W Garvie
Journal:  J Mol Biol       Date:  2010-08-21       Impact factor: 5.469

8.  Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters.

Authors:  Giovanna Tosi; Nabila Jabrane-Ferrat; B Matija Peterlin
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

Review 9.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

10.  Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.

Authors:  Nabila Jabrane-Ferrat; Nada Nekrep; Giovanna Tosi; Laura J Esserman; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.